Evaluation of Curcumin as a Supplement to Improve Mitotane Effects on Adrenocortical Carcinoma
Cells · 20.08.2026 · 15 (16) · 1498
DOI: 10.3390/cells15161498 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 20.08.2026. Verfasst von Marta Claudia Nocito und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, CS, Italy. Hauptthemen laut MEDLINE: Curcumin, Adrenocortical Carcinoma, Mitotane, Adrenal Cortex Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Fondazione AIRC per la Ricerca sul Cancro ETS.
Abstract (Originalsprache)
For many types of cancer, pre-clinical studies have shown that dietary interventions and supplements can be effective in reducing the toxicity and increasing the efficacy of chemotherapeutics. In this context, the polyphenol curcumin is an attractive molecule. We have previously demonstrated that curcumin inhibits adrenocortical carcinoma (ACC) cell growth, has an impact on ACC cell metabolism, decreasing cholesterol availability and promoting glucose and glutamine metabolism. In this study, we evidenced that curcumin downregulates the transcription factors SF-1 and SREBPs and their targets, while inducing a ROS-dependent, HIF1α- and NRF2-mediated metabolic rewiring. NRF2 sustained an adaptive antioxidant mechanism dependent on glutamine, cysteine, and glycine uptake to support glutathione synthesis and avoid lipid peroxidation. Furthermore, the combination of curcumin with mitotane demonstrated synergistic effects in inhibiting ACC cell viability and reducing steroidogenic gene expression. These synergistic effects were observed with sub-therapeutic doses of mitotane, which are reached by patients who fail to attain the therapeutic plasma concentrations of the drug. Crucially, in vivo, curcumin administration to tumor-free mice significantly upregulated NRF2 expression and preserved liver tissue integrity. These results warrant further preclinical evaluation of the proposed combination therapy, particularly for those patients who fail to achieve or maintain mitotane plasma concentrations in the therapeutic range.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, CS, Italy.
- Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), University of Zurich (UZH), 8091 Zürich, Switzerland.
- Centro Sanitario, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Ponte P. Bucci, 87036 Rende (CS), Italy.
ORCID-Profile: Catia Morelli, Diego Sisci, Vincenzo Pezzi, Rosa Sirianni
Förderung
- Italian Association for Cancer Research
- Fondazione AIRC per la Ricerca sul Cancro ETS
Zitieren
APA
Nocito, M. C., Amico, A., Hamad, T., Cormace, A., Hantel, C., Morelli, C., Sisci, D., Lanzino, M., Pezzi, V., Casaburi, I., & Sirianni, R. (2026). Evaluation of Curcumin as a Supplement to Improve Mitotane Effects on Adrenocortical Carcinoma. Cells, 15(16), 1498. https://doi.org/10.3390/cells15161498
Vancouver
Nocito MC, Amico A, Hamad T, Cormace A, Hantel C, Morelli C, et al. Evaluation of Curcumin as a Supplement to Improve Mitotane Effects on Adrenocortical Carcinoma. Cells. 2026;15(16):1498. doi:10.3390/cells15161498
BibTeX
@article{Nocito2026,
author = {Nocito, Marta Claudia and Amico, Alice and Hamad, Tarig and Cormace, Alessandro and Hantel, Constanze and Morelli, Catia and Sisci, Diego and Lanzino, Marilena and Pezzi, Vincenzo and Casaburi, Ivan and Sirianni, Rosa},
title = {Evaluation of Curcumin as a Supplement to Improve Mitotane Effects on Adrenocortical Carcinoma},
journal = {Cells},
year = {2026},
volume = {15},
number = {16},
pages = {1498},
doi = {10.3390/cells15161498}
}
EUVIMED